ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

JANX Janux Therapeutics Inc

37.70
-0.22 (-0.58%)
Last Updated: 15:01:10
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Janux Therapeutics Inc JANX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.22 -0.58% 37.70 15:01:10
Open Price Low Price High Price Close Price Prev Close
38.35 36.935 39.2289 37.92
more quote information »

Recent News

Date Time Source Heading
3/08/202416:47EDGAR2Form S-8 - Securities to be offered to employees in employee..
3/08/202416:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/08/202416:11EDGAR2Form 8-K - Current report
3/08/202416:01BWJanux Therapeutics Reports Fourth Quarter and Full Year 2023..
2/29/202417:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/29/202417:11EDGAR2Form 8-K - Current report
2/29/202401:22BWJanux Therapeutics Announces Pricing of $296.5 Million..
2/28/202421:55EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
2/28/202417:15EDGAR2Form 8-K - Current report
2/27/202421:50EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/27/202417:23EDGAR2Form 8-K - Current report
2/27/202417:00BWJanux Therapeutics Announces Proposed Public Offering of..
2/26/202416:05BWJanux Announces Encouraging Safety and Efficacy Data in..
2/20/202408:00BWJanux Therapeutics to Host Virtual Event Discussing Updated..
2/09/202416:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/01/202416:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/08/202409:00BWJanux Therapeutics Promotes Co-Founder Tommy DiRaimondo,..
1/03/202416:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202416:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202416:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202416:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202416:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/07/202316:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202316:07EDGAR2Form 8-K - Current report
11/07/202316:01BWJanux Therapeutics Reports Third Quarter 2023 Financial..
9/07/202318:14EDGAR2Form 144 - Report of proposed sale of securities
8/14/202316:33EDGAR2Form 144 - Report of proposed sale of securities
8/08/202316:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202316:17EDGAR2Form 8-K - Current report
8/08/202316:01BWJanux Therapeutics Reports Second Quarter 2023 Financial..
7/18/202317:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
7/18/202316:16EDGAR2Form 8-K - Current report
7/17/202308:45BWJanux Therapeutics Announces Pricing of $60 Million..
7/17/202308:16EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
7/17/202308:06EDGAR2Form 8-K - Current report
7/17/202308:00BWJanux Therapeutics Announces Positive Interim Clinical Data..
6/05/202316:35BWJanux Therapeutics Appoints Zachariah McIver, D.O., Ph.D.,..
5/09/202316:01BWJanux Therapeutics Reports First Quarter 2023 Financial..
4/24/202316:01BWJanux Therapeutics to Participate at Upcoming May 2023..
4/20/202316:01BWJanux Therapeutics Announces First Patient Dosed with..

Your Recent History

Delayed Upgrade Clock